Advertisement
UK markets closed
  • NIKKEI 225

    38,946.93
    -122.75 (-0.31%)
     
  • HANG SENG

    19,220.62
    -415.60 (-2.12%)
     
  • CRUDE OIL

    79.06
    -0.20 (-0.25%)
     
  • GOLD FUTURES

    2,425.60
    -0.30 (-0.01%)
     
  • DOW

    39,872.99
    +66.22 (+0.17%)
     
  • Bitcoin GBP

    55,072.38
    +275.91 (+0.50%)
     
  • CMC Crypto 200

    1,522.58
    +34.03 (+2.29%)
     
  • NASDAQ Composite

    16,832.62
    +37.75 (+0.22%)
     
  • UK FTSE All Share

    4,584.40
    -5.98 (-0.13%)
     

Anika to Participate in the 23rd Annual Needham Virtual Healthcare Conference

Anika Therapeutics Inc.
Anika Therapeutics Inc.

BEDFORD, Mass., April 02, 2024 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that management will participate in the 23rd Annual Needham Virtual Healthcare Conference on Monday, April 8, 2024. Anika will host a virtual presentation with Q&A starting at 2:15pm ET.

Webcast of the presentation and Q&A will be available in the Investor Relations section of Anika’s website, www.anika.com. An archive of the presentation will also be available on the website.

About Anika

Anika Therapeutics, Inc. (NASDAQ: ANIK), is a global joint preservation company that creates and delivers meaningful advancements in early intervention orthopedic care. Leveraging our core expertise in hyaluronic acid and implant solutions, we partner with clinicians to provide minimally invasive products that restore active living for people around the world. Our focus is on high opportunity spaces within orthopedics, including Osteoarthritis Pain Management, Regenerative Solutions, Sports Medicine and Arthrosurface Joint Solutions, and our products are efficiently delivered in key sites of care, including ambulatory surgery centers. Anika’s global operations are headquartered outside of Boston, Massachusetts. For more information about Anika, please visit www.anika.com.

ADVERTISEMENT

ANIKA, ANIKA THERAPEUTICS and the Anika logo are registered trademarks of Anika Therapeutics, Inc.

For Investor Inquiries:
Anika Therapeutics, Inc.
Mark Namaroff, 781-457-9287
Vice President, Investor Relations, ESG and Corporate Communications
investorrelations@anika.com